About Ogenix
Ogenix is a company based in Fort Lauderdale (United States) founded in 2003.. Ogenix has raised $3.66 million across 1 funding round. Ogenix offers products and services including EPIFLO and Wound Supplies. Ogenix operates in a competitive market with competitors including Siren, Reapplix, PulseFlow, TexiSense and Fovera Orthodesign, among others.
- Headquarter Fort Lauderdale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ogenix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.66 M (USD)
in 1 rounds
-
Latest Funding Round
$3.66 M (USD), Series A
Jun 01, 2005
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ogenix
Ogenix offers a comprehensive portfolio of products and services, including EPIFLO and Wound Supplies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable device for continuous oxygen delivery to wounds.
Products supporting wound care and healing processes.
Funding Insights of Ogenix
Ogenix has successfully raised a total of $3.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.66 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.7M
-
First Round
First Round
(01 Jun 2005)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2005 | Amount | Series A - Ogenix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Ogenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ogenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ogenix Comparisons
Competitors of Ogenix
Ogenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siren, Reapplix, PulseFlow, TexiSense and Fovera Orthodesign, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovative foot care solutions are provided by Siren.
|
|
| domain | founded_year | HQ Location |
Developer of patch system for wound healing
|
|
| domain | founded_year | HQ Location |
Diabetic foot ulcers are treated with a boot-shaped compression device.
|
|
| domain | founded_year | HQ Location |
Smart socks and orthotic supports to prevent pressure ulcers in patients with sensory loss
|
|
| domain | founded_year | HQ Location |
Online retailer of ergonomic cushions, pillows, and health support products for daily use.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ogenix
When was Ogenix founded?
Ogenix was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is Ogenix located?
Ogenix is headquartered in Fort Lauderdale, United States. It is registered at Fort Lauderdale, Florida, United States.
Is Ogenix a funded company?
Ogenix is a funded company, having raised a total of $3.66M across 1 funding round to date. The company's 1st funding round was a Series A of $3.66M, raised on Jun 01, 2005.
What does Ogenix do?
Ogenix develops and markets the Epiflo which is used for the treatment of wounds which are complications of diabetes, wherein the device provides a flow of continuous pure oxygen directly to the wound bed. The device received FDA 510(k) clearance (K120764), CE Mark, and is also cleared by Health Canada. The device has been used by doctors, hospitals, skilled nursing facilities, and long-term care facilities for treatment of bed sores, diabetic foot ulcers, venous leg ulcers, skin grafts, burns, etc.
Who are the top competitors of Ogenix?
What products or services does Ogenix offer?
Ogenix offers EPIFLO and Wound Supplies.